Michael Williams

Michael Williams is a prominent figure in the healthcare and technology sectors, currently serving as a Board Member at Sarcio Inc. He has over 30 years of experience in these fields, focusing on healthcare innovation and the growth of emerging pharmaceutical and biotech companies. His role at Sarcio involves overseeing the development of regenerative therapies aimed at delaying or preventing joint replacement surgeries for patients with osteoarthritis.12

Professional Background

• Current Position: Board Member at Sarcio Inc. since June 2021.
• Other Roles: He is also a Partner at PACE Healthcare Capital and has previously held positions such as Director at PYC Therapeutics Limited and Private Equity Investor at both Bristol-Myers Squibb and Pfizer.134
• Education: He holds a graduate degree from the University of Bangor.1

Contributions to Sarcio Inc.

At Sarcio, Williams contributes to the company's mission of providing innovative regenerative cell therapies. The company was founded in 2017 and is based in St. Paul, Minnesota. It aims to improve patient quality of life by addressing cartilage breakdown and inflammation through advanced therapeutic solutions.2

Additional Information

Williams is recognized for his leadership in various capacities within the healthcare sector, leveraging his extensive experience to guide strategic initiatives and foster innovation in medical treatments.2